Loading company details...
Beta
Latest Form 4 (Sep 28, 2026): William Franklin Mudd (Senior Vice President, Chief Financial Officer): Exercise/Conversion of 38,282 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 28, 2026 | William Franklin Mudd, Senior Vice President, Chief Financial Officer | Exercise/Conversion | 38,282 | n/a |
| Sep 28, 2026 | Robert Weir, Senior Vice President, Operations & Regulatory Support | Exercise/Conversion | 23,450 | n/a |
| Sep 28, 2026 | John Ackerman | Exercise/Conversion | 1,413,939 | n/a |
| Sep 28, 2026 | Thomas J. Salentine Jr. | Exercise/Conversion | 6,100,175 | n/a |
| Sep 28, 2026 | David Norman Martin, Senior Vice President, Technology, Data & Senior Security Officer | Exercise/Conversion | 39,865 | n/a |
| Sep 28, 2026 | Pharmacy Investors, LLC | Exercise/Conversion | 1,413,939 | n/a |
| Sep 28, 2026 | Fred Burke, President and Chief Executive Officer | Exercise/Conversion | 1,298,825 | n/a |
| Sep 28, 2026 | Jeffrey Tuch, Senior Vice President, Purchasing & Pricing Analytics | Exercise/Conversion | 55,578 | n/a |
| Sep 28, 2026 | Kendall Forbes | Exercise/Conversion | 608,570 | n/a |
| Sep 28, 2026 | William E. Bindley | Exercise/Conversion | 6,100,175 | n/a |